Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther Ads (NQ: ADAP )

5.080 USD +0.200 (+4.10%)
Official Closing Price Updated: 4:41 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adaptimmune Ther Ads

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Biggest Movers in Manufacturing Stocks Now – TTNP JAGX LPTH CTMX
 
Tags NYSE:CC NASDAQ:CTMX NYSE:TREC
From InvestorPlace
Adaptimmune Expands T-cell Engineering Expertise to Develop Affinity Enhanced T-cell Therapies for Autoimmune Indications
Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it is expanding its T-cell therapy development activities to... 
From GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – SKY COLL HSGX ADAP
 
Tags NASDAQ:BELFA NYSE:BPT AMEX:RVP
From InvestorPlace
Hottest Manufacturing Stocks Now – CBIO TGI XRM ANTH
 
Tags NASDAQ:ANTH NYSE:XRM NASDAQ:ACRS
From InvestorPlace
Biggest Movers in Manufacturing Stocks Now – COYN AVID FSYS CTMX
 
Tags Hot Stocks NYSE:LNN NASDAQ:WVE
From InvestorPlace
Adaptimmune Announces Initiation of Study to Evaluate its New Affinity Enhanced T-Cell Therapy Targeting MAGE-A10 in Patients With NSCLC, the Most Common Form of Lung Cancer
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced... 
From GlobeNewswire News Releases
Adaptimmune Wins Scrip Award for Financing Deal of the Year
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has won the Financing Deal of the Year Award at the 2015 Scrip... 
From GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – RTTR GIII CYTK XBIT
 
Tags NASDAQ:GSM NASDAQ:RTTR NASDAQ:XBIT
From InvestorPlace
Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, and Seattle-based Universal Cells Inc., a genome editing company developing universal... 
From GlobeNewswire News Releases
Adaptimmune Initiates Phase I / II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients With the Most Common Type of Lung Cancer
Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in the use of engineered T-cell therapy to treat cancer, today announced that it ... 
Tags Press Releases News ADAP
From Benzinga
Adaptimmune Initiates Phase I / II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients With the Most Common Type of Lung Cancer
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of engineered T-cell therapy to treat cancer, today announced that it has initiated a study of its affinity enhanced T-cell therapy... 
From GlobeNewswire News Releases
Hottest Manufacturing Stocks Now – TASR ATNM PRTK MRNS
 
Tags NYSE:MT NASDAQ:IMGN NASDAQ:TASR
From InvestorPlace
Hottest Manufacturing Stocks Now – MYOS VII SVT SPCB
 
Tags NASDAQ:FLIR AMEX:SVT NASDAQ:ZFGN
From InvestorPlace
Adaptimmune Reports First Quarter Financial Results for Fiscal Year 2015-16
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of T-cell therapy to treat cancer, today reported financial results for the first quarter, which ended September 30, 2015. 
From GlobeNewswire News Releases
Adaptimmune to Participate in the Jefferies Autumn 2015 Global Healthcare Conference
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of T-cell therapy to treat cancer, today announced that James Noble, Chief Executive Officer of Adaptimmune, will present at the... 
From GlobeNewswire News Releases
Hottest Manufacturing Stocks Now – KOP MNST OLED TDC
 
Tags NASDAQ:MNST NASDAQ:INFI NASDAQ:ACAD
From InvestorPlace
Hottest Manufacturing Stocks Now – RGNX KOP WPRT FSYS
 
Tags NASDAQ:GSM NASDAQ:MDVN NASDAQ:TANH
From InvestorPlace
Hottest Manufacturing Stocks Now – EYEG PAR USNA CVU
 
Tags NYSE:PAR NASDAQ:ALQA NASDAQ:AKRX
From InvestorPlace
Adaptimmune Announces Data From Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer
Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today presents ... 
Tags Press Releases FDA News
From Benzinga
Adaptimmune Announces Data From Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today presents updated data on its lead clinical program, an affinity enhanced T-cell... 
From GlobeNewswire News Releases
Adaptimmune Announces Upcoming Data Presentation at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that it will present new data from trials of... 
From GlobeNewswire News Releases
Hottest Manufacturing Stocks Now – ADAP SYN ARMH ORPN
 
Tags NASDAQ:PRCP Hot Stocks NASDAQ:ORPN
From InvestorPlace
Higher close on M&A activity
The markets closed modestly higher with the Dow rising 14 points to 17,230 despite a drop in crude oil prices as investors focused on merger and acquisition activity. Nasdaq gained 18 points to 4,905. 
Tags Market News
From MarketMinute.com Market Updates
Higher close on M&A activity
Tags DHRM CRS HEAR
From MarketMinute » Market Updates
Hottest Manufacturing Stocks Now – ICAD FGEN NWBO ADAP
 
Tags NASDAQ:ADAP NYSE:VRX NASDAQ:FGEN
From InvestorPlace
Adaptimmune to Participate in the 2015 BIO Investor Forum
Adaptimmune Therapeutics plc (Nasdaq:ADAP), (“Adaptimmune” or the “Company”), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that Helen... 
From GlobeNewswire News Releases
Adaptimmune Reports Full Fiscal Year 2015 Financial Results
Conference Call to be Held Today at 8:00 AM ET (1:00 PM BST) 
From GlobeNewswire News Releases
Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia
Company Selects The Navy Yard as Site for U.S. Headquarters and Base for Clinical and Manufacturing Operations 
From GlobeNewswire News Releases
Adaptimmune to Report Full Fiscal Year 2015 Financial Results on October 13, 2015
Adaptimmune Therapeutics plc (Nasdaq:ADAP), (“Adaptimmune” or the “Company”), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, will announce financial... 
From GlobeNewswire News Releases
Adaptimmune Announces New Research and Development Facility in Oxfordshire
'Enterprise Zone' Building Will House Company's Expanding R&D Operation 
From GlobeNewswire News Releases
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.